Neuroleptic activity of the neuropeptide beta-LPH62-77 ([Des-Tyr1]gamma-endorphin; DT gamma E)

European Journal of Pharmacology
D De WiedH M Greven

Abstract

No abstract listed.

References

Aug 15, 1975·Biochemical Pharmacology·D de WiedH M Greven
Jan 1, 1977·Journal of Neural Transmission·L M GunneL Terenius
Jul 1, 1977·Neuropharmacology·H RigterH van Riezen
Oct 28, 1977·Science·D S SegalR Guillemin

❮ Previous
Next ❯

Citations

Jan 1, 1981·Psychopharmacology·G H WienekeW Storm van Leeuwen
Aug 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·U HavemannK Kuschinsky
Jan 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·U Havemann, K Kuschinsky
Jul 1, 1988·Biulleten' eksperimental'noĭ biologii i meditsiny·Iu V DrozdV S Shashkov
Mar 11, 1985·Brain Research·S Amir, J M van Ree
Dec 20, 1979·European Journal of Pharmacology·N W PedigoH I Yamamura
May 2, 1980·European Journal of Pharmacology·W H GispenD De Wied
Nov 19, 1981·European Journal of Pharmacology·A NeilL Terenius
Jan 5, 1981·European Journal of Pharmacology·J M WalkerH Akil
Jun 4, 1982·European Journal of Pharmacology·E SinegerJ I Székely
May 7, 1982·European Journal of Pharmacology·R A Lahti, D D Gay
Sep 24, 1982·European Journal of Pharmacology·S L CohenT N Chase
Nov 5, 1982·European Journal of Pharmacology·J M WalkerH Akil
Sep 16, 1983·European Journal of Pharmacology·J M Van ReeD De Wied
Jul 15, 1983·European Journal of Pharmacology·M FeketeG Telegdy
Jul 22, 1983·European Journal of Pharmacology·E A YoungH Akil
Feb 10, 1984·European Journal of Pharmacology·M FeketeG Telegdy
Jan 2, 1985·European Journal of Pharmacology·A M DucheminR J Wyatt
Jan 15, 1985·European Journal of Pharmacology·H C Moises, J M Walker
Aug 22, 1989·European Journal of Pharmacology·E A YoungH Akil
Aug 11, 1994·European Journal of Pharmacology·A CapassoA Loizzo
Jan 1, 1983·Vision Research·J E DowlingK J Watling
Jun 1, 1979·Pharmacology, Biochemistry, and Behavior·D M DorsaD De Wied
Jan 1, 1980·Pharmacology, Biochemistry, and Behavior·R E ChipkinK Channabasavaiah
Oct 1, 1982·Pharmacology, Biochemistry, and Behavior·D B RondeauD Hebert
Jun 1, 1986·Pharmacology, Biochemistry, and Behavior·H Szechtman
Jul 1, 1990·Pharmacology, Biochemistry, and Behavior·S de Boer, B Bohus
Jan 1, 1979·Neuroscience and Biobehavioral Reviews·G A OlsonD H Coy
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·S T Mason
Jan 1, 1984·Pharmacology & Therapeutics·I J Urban
Jan 1, 1984·Pharmacology & Therapeutics·B Bohus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.